🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objectives: To demonstrate that REPEVAX and VAXIGRIP administered ...
Status
Completed
Location
Sanofi Pasteur MSD Investigational Site
Start Date
2010-10
Trial ID
NCT01249183
Treatments Being Tested
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
The present clinical study will assess the immunogenicity and reactogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00319852
Treatments Being Tested
To assess the immunogenicity profile of ADACEL™, Tetanus and Diphtheria Tox...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00258908
Treatments Being Tested
The present clinical study will assess the immunogenicity and reactogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00254969
Treatments Being Tested
The present clinical study will assess the immunogenicity and reactogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00255021
Treatments Being Tested
An open clinical trial to study the immune response and safety after giving...
Status
Completed
Location
Norwegian Institute of Public Health
Start Date
2007-04
Trial ID
NCT00514059
Treatments Being Tested
As per request by the Heath Authorities, the present clinical study will as...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00453570
The impact of chronic HIV infection and pregnancy on different aspects of t...
Status
Completed
Location
CHU Saint-Pierre
Start Date
2017-03-01
Trial ID
NCT03519373
Treatments Being Tested
The purpose of this study is to evaluate the persistence of immune response...
Status
Completed
Location
Site 02, Center for Vaccinology (CEVAC), Ghent University Hospital
Start Date
2015-04
Trial ID
NCT02382913
Treatments Being Tested